Nektar Therapeutics
NKTR
$1.32
Share price
0.00%
Change (1 day)
76.00%
Change (1 year)
Categories
EPS for Nektar Therapeutics (NKTR)
EPS in 2023 (TTM): -$1.63
According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.63. In 2022 the company made an earnings per share (EPS) of -$1.97 an increase over its 2021 EPS that were of -$2.86.
EPS history for Nektar Therapeutics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.63 | -17.26% |
| 2022 | -$1.97 | -31.12% |
| 2021 | -$2.86 | 14.86% |
| 2020 | -$2.49 | -1.19% |
| 2019 | -$2.52 | -163.96% |
| 2018 | $3.94 | -725.4% |
| 2017 | -$0.63 | -42.73% |
| 2016 | -$1.10 | 83.33% |
| 2015 | -$0.60 | 39.53% |
| 2014 | -$0.43 | -69.29% |
| 2013 | -$1.40 | -6.67% |
| 2012 | -$1.50 | 26.05% |
| 2011 | -$1.19 | 190.24% |
| 2010 | -$0.41 | -63.06% |
| 2009 | -$1.11 | 200% |
| 2008 | -$0.37 | 2.78% |
| 2007 | -$0.36 | -79.19% |
| 2006 | -$1.73 | -19.91% |
| 2005 | -$2.16 | 57.66% |
| 2004 | -$1.37 | 63.1% |
| 2003 | -$0.84 | -56.7% |
| 2002 | -$1.94 | -59.33% |
| 2001 | -$4.77 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -964.13% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | -214.11% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | -968.10% | 🇺🇸 USA |
 Baxter BAX | $5.12 | -414.11% | 🇺🇸 USA |
 Merck MRK | $1.82 | -211.76% | 🇺🇸 USA |
 AstraZeneca AZN | $1.98 | -221.78% | 🇬🇧 UK |
 Richardson Electronics RELL | $1.24 | -176.07% | 🇺🇸 USA |
 Alkermes ALKS | $1.30 | -179.75% | 🇮🇪 Ireland |